KAS
AMRX icon

Kestra Advisory Services’s Amneal Pharmaceuticals AMRX Stock Holding History

Kestra Advisory Services’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,045
Closed -$127K – 3162
2025
Q4 		$127K Buy
+10,045
New +$115K ﹤0.01% 3245
2024
Q2 		– Sell
-30,250
Closed -$183K – 2616
2024
Q1 		$183K Buy
30,250
+4,999
+20% +$28.2K ﹤0.01% 2301
2023
Q4 		$153K Buy
25,251
+1
+0% +$4 ﹤0.01% 2155
2023
Q3 		$107K Sell
25,250
-1,400
-5% -$5.22K ﹤0.01% 2015
2023
Q2 		$82.6K Hold
26,650
– – ﹤0.01% 2016
2023
Q1 		$37K Sell
26,650
-658
-2% -$1.31K ﹤0.01% 2004
2022
Q4 		$54.3K Buy
27,308
+1,471
+6% +$3.3K ﹤0.01% 2174
2022
Q3 		$52K Sell
25,837
-649
-2% -$1.82K ﹤0.01% 2028
2022
Q2 		$84K Buy
26,486
+814
+3% +$2.95K ﹤0.01% 2003
2022
Q1 		$107K Buy
25,672
+299
+1% +$1.32K ﹤0.01% 1927
2021
Q4 		$122K Sell
25,373
-1,511
-6% -$7.53K ﹤0.01% 1929
2021
Q3 		$144K Buy
+26,884
New +$135K ﹤0.01% 2023

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Kestra Advisory Services's AMRX Position: Q1 2026 in Review

Kestra Advisory Services sold out of Amneal Pharmaceuticals (AMRX) in Q1 2026, closing a stake of 10,045 shares — an estimated $127K sold.

Kestra Advisory Services first reported a position in AMRX in Q3 2021 and held it in 12 quarters. The position peaked at $183K in Q1 2024. 317 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Kestra Advisory Services reported no remaining Amneal Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 10,045 Amneal Pharmaceuticals shares in Q1 2026, an estimated $127K.
  • Kestra Advisory Services first reported a position in Amneal Pharmaceuticals in Q3 2021 and held it in 12 quarters.
  • Kestra Advisory Services's Amneal Pharmaceuticals position peaked at $183K in Q1 2024.
  • 317 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.